journal article·2024-02-28Open access

Cellular senescence and nanoparticle-based therapies: Current developments and perspectives

Agata Henschke, Angelika Mielcarek, Bartosz Grześkowiak, Patrick M. Perrigue, Kaja Jaskot, Emerson Coy, Sergio Moya

Nanotechnology Reviews· Volume 13· Issue 1

Abstract

Abstract The timing and location of senescent cells in vivo is a leading candidate explanation for human aging. A rapidly developing scientific field with the potential to slow the aging process is the creation of pharmacologically active medicines that target senescent cells. Senotherapeutics have been developed to selectively or preferentially target and eliminate senescent cells. Senolytic compounds that delay aging in animal models are being explored in humans with great hope. Nanoparticle (NP) drug delivery strategies for targeting senescent cells are in their infancy, but advancements have been made, and preliminary anti-aging applications are promising. However, using nanomedicine effectively requires an understanding of how NPs behave in senescent cells. Senescence theranostics could offer a variety of information, including a prognostic predictor in cancer patients after treatment. The NPs have a much better outlook for translating it to the clinic for aging. Reversing aging pathologies may only require a percentage reduction in senescent cells to achieve therapeutic success, in contrast to cancer, where it is essential to eradicate the tumor. This review provides an overview of the factors that lead to senescence and different therapeutic approaches, focusing on the use of nanocarriers/particles in senotherapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Telomeres, Telomerase, and Senescence · Advanced biosensing and bioanalysis techniques · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

NanoBioMedical Centre, Adam Mickiewicz University , Wszechnicy Piastowskiej 3, 61-614 , Poznan , Poland

Centre for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA) , Paseo Miramon 182 C, 20014 Donostia-San Sebastian , Spain

References (100+)

Show source-provided references
1. Birch J, Gil J. Senescence and the SASP: many therapeutic avenues. 2020;34:1565–76. 10.1101/gad.343129.10.1101/gad.343129.120 ↗
2. Wang B, Kohli J, Demaria M. Senescent cells in cancer therapy: Friends or foes?. Trends Cancer. 2020 Oct;6(10):838–57. Cell Press. 10.1016/j.trecan.2020.05.004.10.1016/j.trecan.2020.05.004 ↗
3. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Experimental Cell Res. 1961;25:585–621.10.1016/0014-4827(61)90192-6 ↗
4. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. Mar 1965;37(3):614–36. 10.1016/0014-4827(65)90211-9.10.1016/0014-4827(65)90211-9 ↗
5. Pfeffer CM, Singh ATK. Apoptosis: A target for anticancer therapy. Int J Mol Sci. Feb 2018;19(2):448. MDPI AG. 10.3390/ijms19020448.10.3390/ijms19020448 ↗
6. Rodier F, Coppé JP, Patil CK, Hoeijmakers WA, Muñoz DP, Raza SR, et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol. Aug. 2009;11(8):973–9. 10.1038/ncb1909.10.1038/ncb1909 ↗
7. Neurohr GE, Terry RL, Lengefeld J, Bonney M, Brittingham GP, Moretto F, et al. Excessive cell growth causes cytoplasm dilution and contributes to senescence. Cell. Feb. 2019;176(5):1083–97.e18. 10.1016/j.cell.2019.01.018.10.1016/j.cell.2019.01.018 ↗
8. Bojko A, Czarnecka-Herok J, Charzynska A, Dabrowski M, Sikora E. Diversity of the senescence phenotype of cancer cells treated with chemotherapeutic agents. Cells. Dec. 2019;8:12. 10.3390/cells8121501.10.3390/cells8121501 ↗
9. Perrigue PM, Rakoczy M, Pawlicka KP, Belter A, Giel-Pietraszuk M, Naskręt-Barciszewska M, et al. Cancer stem cell-inducing media activates senescence reprogramming in fibroblasts. Cancers. Jun. 2020;12(7):1745. 10.3390/cancers12071745.10.3390/cancers12071745 ↗
10. Wang AS, Dreesen O. Biomarkers of cellular senescence and skin aging. Front Genet. Aug, 2018;9:247. Front Media SA. 10.3389/fgene.2018.00247.10.3389/fgene.2018.00247 ↗
11. Aird KM, Zhang R. Detection of senescence-associated heterochromatin foci (SAHF). Methods Mol Biol. 2013;965:185–96. 10.1007/978-1-62703-239-1_12.10.1007/978-1-62703-239-1_12 ↗
12. Lee S, Jeong SY, Lim WC, Kim S, Park YY, Sun X, et al. Mitochondrial fission and fusion mediators, hFis1 and OPA1, modulate cellular senescence. J Biol Chem. Aug. 2007;282(31):22977–83. 10.1074/jbc.M700679200.10.1074/jbc.M700679200 ↗
13. Gorgoulis V, Adams PD, Alimonti A, Bennett DC, Bischof O, Bishop C, et al. Cellular senescence: Defining a path forward. Cell. Oct, 2019;179(4):813–27. Cell Press 10.1016/j.cell.2019.10.005.10.1016/j.cell.2019.10.005 ↗
14. Basisty N, Kale A, Jeon OH, Kuehnemann C, Payne T, Rao C, et al. A proteomic atlas of senescence-associated secretomes for aging biomarker development. PLoS Biol. Jan. 2020;18(1):e3000599. 10.1371/journal.pbio.3000599.10.1371/journal.pbio.3000599 ↗
15. Chambers CR, Ritchie S, Pereira BA, Timpson P. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer. Mol Oncol. Dec 2021;15(12):3242–55. John Wiley and Sons Ltd. 10.1002/1878-0261.13042.10.1002/1878-0261.13042 ↗
16. Coppé JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: The dark side of tumor suppression. Annu Rev Pathol. Feb. 2010;5:99–118. 10.1146/annurev-pathol-121808-102144.10.1146/annurev-pathol-121808-102144 ↗
17. Kim SR, Puranik AS, Jiang K, Chen X, Zhu XY, Taylor I, et al. Progressive cellular senescence mediates renal dysfunction in ischemic nephropathy. J Am Soc Nephrol. Aug. 2021;32(8):1987–2004. 10.1681/ASN.2020091373.10.1681/ASN.2020091373 ↗
18. Muñoz-Galván S, Lucena-Cacace A, Perez M, Otero-Albiol D, Gomez-Cambronero J, Carnero A. Tumor cell-secreted PLD increases tumor stemness by senescence-mediated communication with microenvironment. Oncogene. Feb. 2019;38(8):1309–23. 10.1038/s41388-018-0527-2.10.1038/s41388-018-0527-2 ↗
19. Hao X, Zhao B, Zhou W, Liu H, Fukumoto T, Gabrilovich D, et al. Sensitization of ovarian tumor to immune checkpoint blockade by boosting senescence-associated secretory phenotype. iScience. Jan. 2021;24(1):102016. 10.1016/j.isci.2020.102016.10.1016/j.isci.2020.102016 ↗
20. Marin I, Boix O, Garcia-Garijo A, Sirois I, Caballe A, Zarzuela E, et al. Cellular senescence is immunogenic and promotes antitumor immunity. Cancer Discovery. Feb. 2023;13(2):410–31. 10.1158/2159-8290.CD-22-0523.10.1158/2159-8290.CD-22-0523 ↗
21. Chen H-A, Ho YJ, Mezzadra R, Adrover JM, Smolkin R, Zhu C, et al. Senescence rewires microenvironment sensing to facilitate antitumor immunity. Cancer Discovery. Feb. 2023;13(2):432–53. 10.1158/2159-8290.CD-22-0528.10.1158/2159-8290.CD-22-0528 ↗
22. Huss R. “Biomarkers,” in Translational Regenerative Medicine. Academic Press; 2015. p. 235–41. 10.1016/B978-0-12-410396-2.00019-0.10.1016/B978-0-12-410396-2.00019-0 ↗
23. Tominaga T, Shimada R, Okada Y, Kawamata T, Kibayashi K. Senescence-associated-β-galactosidase staining following traumatic brain injury in the mouse cerebrum. PLoS One. Mar. 2019;14(3):0213673. 10.1371/journal.pone.0213673.10.1371/journal.pone.0213673 ↗
24. Chang B-D, Xuan Y, Broude EV, Zhu H, Schott B, Fang J, et al. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene. Aug. 1999;18(34):4808–18. 10.1038/sj.onc.1203078.10.1038/sj.onc.1203078 ↗
25. Leontieva Ov, Gudkov Av, Blagosklonny Mv. Weak p53 permits senescence during cell cycle arrest. Cell Cycle. Nov. 2010;9(21):4323–7. 10.4161/cc.9.21.13584.10.4161/cc.9.21.13584 ↗
26. Foroozandeh P, Aziz AA, Mahmoudi M. Effect of cell age on uptake and toxicity of nanoparticles: The overlooked factor at the nanobio interface. ACS Appl Mater Interfaces. Oct. 2019;11(43):39672–87. 10.1021/acsami.9b15533.10.1021/acsami.9b15533 ↗
27. Suda M, Shimizu I, Katsuumi G, Yoshida Y, Hayashi Y, Ikegami R, et al. Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice. Nat Aging. Dec. 2021;1(12):1117–26. 10.1038/s43587-021-00151-2.10.1038/s43587-021-00151-2 ↗
28. Sugizaki T, Zhu S, Guo G, Matsumoto A, Zhao J, Endo M, et al. Treatment of diabetic mice with the SGLT2 inhibitor TA-1887 antagonizes diabetic cachexia and decreases mortality. NPJ Aging Mech Dis. Dec 2017;3(1):12. 10.1038/s41514-017-0012-0.10.1038/s41514-017-0012-0 ↗
29. Camps J, Erdos MR, Ried T. The role of lamin Bl for the maintenance of nuclear structure and function. Nucleus. Jan 2015;6(1):8–14. 10.1080/19491034.2014.1003510.10.1080/19491034.2014.1003510 ↗
30. Freund A, Laberge R-M, Demaria M, Campisi J. Lamin B1 loss is a senescence-associated biomarker. Mol Biol Cell. Jun 2012;23(11):2066–75. 10.1091/mbc.e11-10-0884.10.1091/mbc.e11-10-0884 ↗
31. Kumari R, Jat P. Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype. Front Cell Dev Biol. Frontiers Media S.A. Mar, 2021;9:645593. 10.3389/fcell.2021.645593.10.3389/fcell.2021.645593 ↗
32. Nikitaki Z, Hellweg CE, Georgakilas AG, Ravanat JL. Stress-induced DNA damage biomarkers: Applications and limitations. Front Chem. Jun 2015;3:35. Frontiers Media S.A. 10.3389/fchem.2015.00035.10.3389/fchem.2015.00035 ↗
33. El-Far AH, Darwish NHE, Mousa SA. Senescent colon and breast cancer cells induced by doxorubicin exhibit enhanced sensitivity to curcumin, caffeine, and thymoquinone. Integr Cancer Ther. 2020;19:1534735419901160. 10.1177/1534735419901160.10.1177/1534735419901160 ↗
34. Piegari E, De Angelis A, Cappetta D, Russo R, Esposito G, Costantino S, et al. Doxorubicin induces senescence and impairs function of human cardiac progenitor cells. Basic Res Cardiol. Jan. 2013;108:2. 10.1007/s00395-013-0334-4.10.1007/s00395-013-0334-4 ↗
35. Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz DP, Goldstein J, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008;6(12):2853–68. 10.1371/journal.pbio.0060301.10.1371/journal.pbio.0060301 ↗
36. Rana T, Jiang C, Liu G, Miyata T, Antony V, Thannickal VJ, et al. PAI-1 Regulation of TGF-β1–induced Alveolar Type II Cell Senescence, SASP Secretion, and SASP-mediated Activation of Alveolar Macrophages. Am J Respir Cell Mol Biol. Mar. 2020;62(3):319–30. 10.1165/rcmb.2019-0071OC.10.1165/rcmb.2019-0071OC ↗
37. Zu C, Qin G, Yang C, Liu N, He A, Zhang M, et al. Low dose Emodin induces tumor senescence for boosting breast cancer chemotherapy via silencing NRARP. Biochem Biophys Res Commun. Nov. 2018;505(4):973–8. 10.1016/j.bbrc.2018.09.045.10.1016/j.bbrc.2018.09.045 ↗
38. Özcan S, Alessio N, Acar MB, Mert E, Omerli F, Peluso G, et al. Unbiased analysis of senescence associated secretory phenotype (SASP) to identify common components following different genotoxic stresses. Aging. Jun. 2016;8(7):1316–29. 10.18632/aging.100971.10.18632/aging.100971 ↗
39. Bang M, Kim DG, Gonzales EL, Kwon KJ, Shin CY. Etoposide induces mitochondrial dysfunction and cellular senescence in primary cultured rat astrocytes. Biomol Ther. 2019;27(6):530–9. 10.4062/biomolther.2019.151.10.4062/biomolther.2019.151 ↗
40. Demaria M, O'Leary MN, Chang J, Shao L, Liu S, Alimirah F, et al. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discovery. Feb. 2017;7(2):165–76. 10.1158/2159-8290.CD-16-0241.10.1158/2159-8290.CD-16-0241 ↗
41. Fallah M, Mohammadi H, Shaki F, Hosseini-Khah Z, Moloudizargari M, Dashti A, et al. Doxorubicin and liposomal doxorubicin induce senescence by enhancing nuclear factor kappa B and mitochondrial membrane potential. Life Sci. Sep. 2019;232:116677. 10.1016/j.lfs.2019.116677.10.1016/j.lfs.2019.116677 ↗
42. Taubenberger Av, Baum B, Matthews HK. The mechanics of mitotic cell rounding. Front Cell Dev Biol. Aug. 2020;8:687. Frontiers Media S.A. 10.3389/fcell.2020.00687.10.3389/fcell.2020.00687 ↗
43. Victorelli S, Passos JF. Telomeres and cell senescence – size matters not. EBioMedicine. Jul, 2017;21:14–20. Elsevier B.V. 10.1016/j.ebiom.2017.03.027.10.1016/j.ebiom.2017.03.027 ↗
44. Liu M-H, Yu W-T, Liu M, Zhang Y, Wang L-J, Zhang C-Y. Enzymatic DNA repair cascade-driven fluorophore encoding for sensitively sensing telomerase activity in cancer cells. Sens Actuators B Chem. May 2022;359:131603. 10.1016/j.snb.2022.131603.10.1016/j.snb.2022.131603 ↗
45. Gal H, Krizhanovsky V. Cell fusion induced senescence. Aging. May 2014;6(5):353–4. 10.18632/aging.100670.10.18632/aging.100670 ↗
46. Burton DGA, Krizhanovsky V. Physiological and pathological consequences of cellular senescence. Cell Mol Life Sci. Oct. 2014;71(22):4373–86. Birkhauser Verlag AG. 10.1007/s00018-014-1691-3.10.1007/s00018-014-1691-3 ↗
47. Kajdy A, Modzelewski J, Cymbaluk-Płoska A, Kwiatkowska E, Bednarek-Jędrzejek M, Borowski D, et al. Molecular pathways of cellular senescence and placental aging in late fetal growth restriction and stillbirth. Int J Mol Sci. Apr. 2021;22(8):4186. MDPI AG. 10.3390/ijms22084186.10.3390/ijms22084186 ↗
48. Da Silva-Álvarez S, Guerra-Varela J, Sobrido-Cameán D, Quelle A, Barreiro-Iglesias A, Sánchez L, et al. Cell senescence contributes to tissue regeneration in zebrafish. Aging Cell. Jan. 2020;19(1):13052. 10.1111/acel.13052.10.1111/acel.13052 ↗
49. Mikuła-Pietrasik J, Niklas A, Uruski P, Tykarski A, Książek K. Mechanisms and significance of therapy-induced and spontaneous senescence of cancer cells. Cell Mol Life Sci. Jan. 01, 2020;77(2):213–29. Springer. 10.1007/s00018-019-03261-8.10.1007/s00018-019-03261-8 ↗
50. González-Gualda E, Baker AG, Fruk L, Muñoz-Espín D. A guide to assessing cellular senescence in vitro and in vivo. FEBS J. Jan. 2021;288(1):56–80. 10.1111/febs.15570.10.1111/febs.15570 ↗
51. Mijit M, Caracciolo V, Melillo A, Amicarelli F, Giordano A. Role of p53 in the regulation of cellular senescence. Biomolecules. Mar. 2020;10(3):420. MDPI AG. 10.3390/biom10030420.10.3390/biom10030420 ↗
52. Pole A, Dimri M, Dimri GP. Oxidative stress, cellular senescence and ageing. AIMS Mol Sci. 2016;3(3):300–24. 10.3934/molsci.2016.3.300.10.3934/molsci.2016.3.300 ↗
53. Zuo L, Zhou T, Pannell BK, Ziegler AC, Best TM. Biological and physiological role of reactive oxygen species - the good, the bad and the ugly. Acta Physiologica. Jul. 2015;214(3):329–48. Blackwell Publishing Ltd. 10.1111/apha.12515.10.1111/apha.12515 ↗
54. Sheng Z, Oka S, Tsuchimoto D, Abolhassani N, Nomaru H, Sakumi K, et al. 8-Oxoguanine causes neurodegeneration during MUTYH-mediated DNA base excision repair. J Clin Invest. Dec. 2012;122(12):4344–61. 10.1172/JCI65053.10.1172/JCI65053 ↗
55. Davalli P, Mitic T, Caporali A, Lauriola A, D’Arca D. ROS, cell senescence, and novel molecular mechanisms in aging and age-related diseases. Oxid Med Cell Longev. 2016;2016:3565127. Hindawi Limited. 10.1155/2016/3565127.10.1155/2016/3565127 ↗
56. Jan Y-H, Heck DE, Laskin DL, Laskin JD. DNA damage signaling in the cellular responses to mustard vesicants. Toxicol Lett. Jun. 2020;326:78–82. 10.1016/j.toxlet.2020.03.008.10.1016/j.toxlet.2020.03.008 ↗
57. Horn G, Schäfers C, Thiermann H, Völkl S, Schmidt A, Rothmiller S. Sulfur mustard single-dose exposure triggers senescence in primary human dermal fibroblasts. Arch Toxicol. Nov. 2022;96(11):3053–66. 10.1007/s00204-022-03346-7.10.1007/s00204-022-03346-7 ↗
58. Soleimani M, Baharnoori SM, Cheraqpour K, Momenaei B, Mirshahi R, Chow C, et al. Cellular senescence implication in mustard keratopathy. Exp Eye Res. Aug. 2023;233:109565. 10.1016/j.exer.2023.109565.10.1016/j.exer.2023.109565 ↗
59. Fitsiou E, Soto-Gamez A, Demaria M. Biological functions of therapy-induced senescence in cancer. Semin Cancer Biol. Jun. 2022;81:5–13. 10.1016/j.semcancer.2021.03.021.10.1016/j.semcancer.2021.03.021 ↗
60. Shokrzadeh M, Bagheri A, Ghassemi-Barghi N, Rahmanian N, Eskandani M. Doxorubicin and doxorubicin-loaded nanoliposome induce senescence by enhancing oxidative stress, hepatotoxicity, and in vivo genotoxicity in male Wistar rats. Naunyn Schmiedebergs Arch Pharmacol. Aug. 2021;394(8):1803–13. 10.1007/s00210-021-02119-w.10.1007/s00210-021-02119-w ↗
61. Saleh T, Bloukh S, Carpenter VJ, Alwohoush E, Bakeer J, Darwish S, et al. Therapy-induced senescence: an ‘old’ friend becomes the enemy. Cancers. Apr. 2020;12(4):822. MDPI AG. 10.3390/cancers12040822.10.3390/cancers12040822 ↗
62. Hu X, Zhang H. Doxorubicin-induced cancer cell senescence shows a time delay effect and is inhibited by epithelial-mesenchymal transition (EMT). Med Sci Monit. 2019;25:3617–23. 10.12659/MSM.914295.10.12659/MSM.914295 ↗
63. Tonnessen-Murray CA, Frey WD, Rao SG, Shahbandi A, Ungerleider NA, Olayiwola JO, et al. Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival. J Cell Biol. Nov. 2019;218(11):3827–44. 10.1083/JCB.201904051.10.1083/jcb.201904051 ↗
64. Wan M, Gray-Gaillard EF, Elisseeff JH. Cellular senescence in musculoskeletal homeostasis, diseases, and regeneration. Bone Res. Sep. 2021;9(1):41. 10.1038/s41413-021-00164-y.10.1038/s41413-021-00164-y ↗
65. Aghali A, Koloko Ngassie ML, Pabelick CM, Prakash YS. Cellular senescence in aging lungs and diseases. Cells. May 2022;11(11):1781. 10.3390/cells11111781.10.3390/cells11111781 ↗
66. Hu C, Zhang X, Teng T, Ma Z-G, Tang Q-Z. Cellular senescence in cardiovascular diseases: A systematic review. Aging Dis. 2022;13(1):103–28. 10.14336/AD.2021.0927.10.14336/AD.2021.0927 ↗
67. Carmona A, Guerrero F, Jimenez MJ, Ariza F, Agüera ML, Obrero T, et al. Inflammation, senescence and MicroRNAs in chronic kidney disease. Front Cell Dev Biol. Aug. 2020;8:739. 10.3389/fcell.2020.00739.10.3389/fcell.2020.00739 ↗
68. Hobson S, Arefin S, Kublickiene K, Shiels P, Stenvinkel P. Senescent cells in early vascular ageing and bone disease of chronic kidney disease – a novel target for treatment. Toxins. Feb. 2019;11(2):82. 10.3390/toxins11020082.10.3390/toxins11020082 ↗
69. Zhao JL, Qiao XH, Mao JH, Liu F, Fu HD. The interaction between cellular senescence and chronic kidney disease as a therapeutic opportunity. Front Pharmacol. Aug. 2022;13:974361. Frontiers Media S.A. 10.3389/fphar.2022.974361.10.3389/fphar.2022.974361 ↗
70. Dai L, Qureshi AR, Witasp A, Lindholm B, Stenvinkel P. Early vascular ageing and cellular senescence in chronic kidney disease. Comput Struct Biotechnol J. Jan. 2019;17:721–9. Elsevier B.V. 10.1016/j.csbj.2019.06.015.10.1016/j.csbj.2019.06.015 ↗
71. Kim H, Yu MR, Lee H, Kwon SH, Jeon JS, Han DC, et al. Metformin inhibits chronic kidney disease-induced DNA damage and senescence of mesenchymal stem cells. Aging Cell. Feb. 2021;20(2):13317. 10.1111/acel.13317.10.1111/acel.13317 ↗
72. Klinkhammer BM, Kramann R, Mallau M, Makowska A, van Roeyen CR, Rong S, et al. Mesenchymal stem cells from rats with chronic kidney disease exhibit premature senescence and loss of regenerative potential. PLoS One. Mar. 2014;9(3):e92115. 10.1371/journal.pone.0092115.10.1371/journal.pone.0092115 ↗
73. Baar MP, Brandt R, Putavet DA, Klein J, Derks K, Bourgeois B, et al. Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell. Mar. 2017;169(1):132–47.e16. 10.1016/j.cell.2017.02.031.10.1016/j.cell.2017.02.031 ↗
74. Fu Q, Qin Z, Yu J, Yu Y, Tang Q, Lyu D, et al. Effects of senescent lens epithelial cells on the severity of age-related cortical cataract in humans. Medicine. Jun. 2016;95(25):e3869. 10.1097/MD.0000000000003869.10.1097/MD.0000000000003869 ↗
75. Soleimani M, Cheraqpour K, Koganti R, Djalilian AR. Cellular senescence and ophthalmic diseases: narrative review. Graefe’s Archive Clin Exp Ophthalmol. Nov. 2023;261(11):3067–82. 10.1007/s00417-023-06070-9.10.1007/s00417-023-06070-9 ↗
76. Skowronska-Krawczyk D, Zhao L, Zhu J, Weinreb RN, Cao G, Luo J, et al. P16INK4a upregulation mediated by SIX6 Defines retinal ganglion cell pathogenesis in glaucoma. Mol Cell. Sep. 2015;59(6):931–40. 10.1016/j.molcel.2015.07.027.10.1016/j.molcel.2015.07.027 ↗
77. Baker DJ, Petersen RC. Cellular senescence in brain aging and neurodegenerative diseases: Evidence and perspectives. J Clin Invest. Apr. 2018;128(4):1208–16. American Society for Clinical Investigation. 10.1172/JCI95145.10.1172/JCI95145 ↗
78. Russo T, Riessland M. Age-related midbrain inflammation and senescence in Parkinson’s disease. Front Aging Neurosci. Jun. 2022;14:917797. 10.3389/fnagi.2022.917797.10.3389/fnagi.2022.917797 ↗
79. Riessland M, Kolisnyk B, Kim TW, Cheng J, Ni J, Pearson JA, et al. Loss of SATB1 Induces p21-dependent cellular senescence in post-mitotic dopaminergic neurons. Cell Stem Cell. Oct. 2019;25(4):514–530.e8. 10.1016/j.stem.2019.08.013.10.1016/j.stem.2019.08.013 ↗
80. Chinta SJ, Woods G, Demaria M, Rane A, Zou Y, McQuade A, et al. Cellular senescence is induced by the environmental neurotoxin paraquat and contributes to neuropathology linked to Parkinson’s disease. Cell Rep. Jan. 2018;22(4):930–40. 10.1016/j.celrep.2017.12.092.10.1016/j.celrep.2017.12.092 ↗
81. Martínez-Cué C, Rueda N. Cellular senescence in neurodegenerative diseases. Front Cell Neurosci. Feb. 2020;14:16. 10.3389/fncel.2020.00016.10.3389/fncel.2020.00016 ↗
82. Wang Q, Duan L, Li X, Wang Y, Guo W, Guan F, et al. Glucose metabolism, neural cell senescence and alzheimer’s disease. Int J Mol Sci. Apr. 2022;23(8):4351. 10.3390/ijms23084351.10.3390/ijms23084351 ↗
83. Selkoe DJ. Alzheimer’s disease. Cold Spring Harb Perspect Biol. Jul. 2011;3(7):a004457. 10.1101/cshperspect.a004457.10.1101/cshperspect.a004457 ↗
84. Nisbet RM, Götz J. Amyloid-β and Tau in Alzheimer’s disease: Novel pathomechanisms and non-pharmacological treatment strategies. J Alzheimer’s Dis. Jun. 2018;64(s1):S517–27. 10.3233/JAD-179907.10.3233/JAD-179907 ↗
85. Guerrero A, De Strooper B, Arancibia-Cárcamo IL. Cellular senescence at the crossroads of inflammation and Alzheimer’s disease. Trends Neurosci. Sep. 2021;44(9):714–27. 10.1016/j.tins.2021.06.007.10.1016/j.tins.2021.06.007 ↗
86. Herdy JR, Traxler L, Agarwal RK, Karbacher L, Schlachetzki J, Boehnke L, et al. Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer’s disease. Cell Stem Cell. Dec. 2022;29(12):1637–52.e6. 10.1016/j.stem.2022.11.010.10.1016/j.stem.2022.11.010 ↗
87. Musi N, Valentine JM, Sickora KR, Baeuerle E, Thompson CS, Shen Q, et al. Tau protein aggregation is associated with cellular senescence in the brain. Aging Cell. Dec. 2018;17:6. 10.1111/acel.12840.10.1111/acel.12840 ↗
88. Caldeira C, Cunha C, Vaz AR, Falcão AS, Barateiro A, Seixas E, et al. Key aging-associated alterations in primary microglia response to beta-amyloid stimulation. Front Aging Neurosci. Aug. 2017;9:277. 10.3389/fnagi.2017.00277.10.3389/fnagi.2017.00277 ↗
89. Lyra e Silva NM, Gonçalves RA, Pascoal TA, Lima-Filho R, Resende E, Vieira E, et al. Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer’s disease. Transl Psychiatry. Jun. 2021;11(1):251. 10.1038/s41398-021-01349-z.10.1038/s41398-021-01349-z ↗
90. Dorigatti AO, Riordan R, Yu Z, Ross G, Wang R, Reynolds-Lallement N, et al. Brain cellular senescence in mouse models of Alzheimer’s disease. Geroscience. Apr. 2022;44(2):1157–68. 10.1007/s11357-022-00531-5.10.1007/s11357-022-00531-5 ↗
91. Akiguchi I, Pallàs M, Budka H, Akiyama H, Ueno M, Han J, et al. SAMP8 mice as a neuropathological model of accelerated brain aging and dementia: Toshio Takeda’s legacy and future directions. Neuropathol. Aug. 2017;37(4):293–305. 10.1111/neup.12373.10.1111/neup.12373 ↗
92. Huang Y, Wu B, Shen D, Chen J, Yu Z, Chen C. Ferroptosis in a sarcopenia model of senescence accelerated mouse prone 8 (SAMP8. Int J Biol Sci. 2021;17(1):151–62. 10.7150/ijbs.53126.10.7150/ijbs.53126 ↗
93. Suzuki T, Aoki K, Shimokobe K, Omiya S, Funayama C, Takahashi T, et al. Age-related morphological and functional changes in the small intestine of senescence-accelerated mouse. Exp Gerontol. Jun. 2022;163:111795. 10.1016/j.exger.2022.111795.10.1016/j.exger.2022.111795 ↗
94. Wang L, Lankhorst L, Bernards R. Exploiting senescence for the treatment of cancer. Nat Rev Cancer. Jun. 2022;22(6):340–55. Nature Research. 10.1038/s41568-022-00450-9.10.1038/s41568-022-00450-9 ↗
95. Schmitt CA, Wang B, Demaria M. Senescence and cancer — role and therapeutic opportunities. Nat Rev Clin Oncol. Oct. 2022;19(10):619–36. Springer Nature. 10.1038/s41571-022-00668-4.10.1038/s41571-022-00668-4 ↗
96. Chambers CR, Ritchie S, Pereira BA, Timpson P. Overcoming the senescence‐associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer. Mol Oncol. Dec. 2021;15(12):3242–55. 10.1002/1878-0261.13042.10.1002/1878-0261.13042 ↗
97. Ortiz-Montero P, Londoño-Vallejo A, Vernot J-P. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line. Cell Commun Signal. Dec. 2017;15(1):17. 10.1186/s12964-017-0172-3.10.1186/s12964-017-0172-3 ↗
98. Ruhland MK, Loza AJ, Capietto AH, Luo X, Knolhoff BL, Flanagan KC, et al. Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis. Nat Commun. Jun. 2016;7(1):11762. 10.1038/ncomms11762.10.1038/ncomms11762 ↗
99. Ritschka B, Storer M, Mas A, Heinzmann F, Ortells MC, Morton JP, et al. The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration. Genes Dev. Jan. 2017;31(2):172–83. 10.1101/gad.290635.116.10.1101/gad.290635.116 ↗
100. Milanovic M, Fan D, Belenki D, Däbritz J, Zhao Z, Yu Y, et al. Senescence-associated reprogramming promotes cancer stemness. Nature. Jan. 2018;553(7686):96–100. 10.1038/nature25167.10.1038/nature25167 ↗